Cure, SJ, Adams, CE. Forensic trials inform the present and future. Br J Psychiatry
2000; 177: 182.
Thornley, B, Adams, C.
Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ
1998; 317: 1181–4.
Hollis, S, Campbell, F.
What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ
1999; 319: 670–4.
Dunn, G, Maracy, M, Tomenson, B.
Estimating treatment effects from randomised clinical trials with non-compliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res
2005; 14: 369–95.
Leucht, S, Engel, RR, Bauml, J, Davis, JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
2007; 33: 183–91.
Marshall, M, Lockwood, A, Bradley, C, Adams, C, Joy, C, Fenton, M.
Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizo-phrenia. Br J Psychiatry
2000; 176: 249–52.
WHO Scientific Group on Treatment of Psychiatric Disorders. Evaluation of Methods for the Treatment of Mental Disorders. World Health Organization, 1991.
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med
2005; 353: 1209–23.
Cotton, SM, Yuen, HP, Berger, G, McGorry, P.
Last observation carried forward in psychiatric research – a flawed gold standard. Aust N Z J Psychiatry
2005; 39: 622.
Bain, MRS, Chalmers, JWT, Brewster, DH. Routinely collected data in national and regional databases – an underused resource. J Public Health Med
1997; 19: 413–8.